Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group

The use of natalizumab for highly active relapsing-remitting multiple sclerosis (MS) is influenced by the occurrence of progressive multifocal leukoencephalopathy (PML). Through measurement of the anti-JCV antibody index, and in combination with the presence or absence of other known risk factors, i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurol Neurosurg Psychiatry
Main Authors: McGuigan, C, Craner, M, Guadagno, J, Kapoor, R, Mazibrada, G, Molyneux, P, Nicholas, R, Palace, J, Pearson, O R, Rog, D, Young, C A
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2016
Assuntos:
Multiple Sclerosis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4752634/
https://ncbi.nlm.nih.gov/pubmed/26492930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2015-311100
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados